30 results
8-K
EX-2.1
STSA
Satsuma Pharmaceuticals Inc
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
is, and since January 1, 2021 has been, in compliance in all material respects with the applicable Nasdaq listing and corporate governance rules
8-K
EX-99.1
4fxjd2s2tybajk1 ob
9 Nov 21
Satsuma Pharmaceuticals Reports Third Quarter 2021 Financial Results
5:00pm
DEF 14A
1kapr
24 Apr 20
Definitive proxy
4:14pm
10-K
rn7 6cp3zdc
10 Mar 20
Annual report
4:20pm
8-K
EX-99.1
2wu02opv7nz15kkv3 8f
10 Mar 20
Satsuma Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Results
4:10pm
10-Q
sz99cu
12 Nov 19
Quarterly report
4:31pm